These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33347317)

  • 1. 2-((3,5-Dinitrobenzyl)thio)quinazolinones: Potent Antimycobacterial Agents Activated by Deazaflavin (F
    Jian Y; Forbes HE; Hulpia F; Risseeuw MDP; Caljon G; Munier-Lehmann H; Boshoff HIM; Van Calenbergh S
    J Med Chem; 2021 Jan; 64(1):440-457. PubMed ID: 33347317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and optimization of a new series of anti-tubercular quinazolinones.
    Couturier C; Lair C; Pellet A; Upton A; Kaneko T; Perron C; Cogo E; Menegotto J; Bauer A; Scheiper B; Lagrange S; Bacqué E
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5290-5299. PubMed ID: 27671498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
    Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE
    Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway.
    Karabanovich G; Fabiánová V; Vocat A; Dušek J; Valášková L; Stolaříková J; Kitson RRA; Pávek P; Vávrová K; Djaout K; Mikušová K; Baulard AR; Cole ST; Korduláková J; Roh J
    J Med Chem; 2024 Jan; 67(1):81-109. PubMed ID: 38157261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DprE1 and Ddn as promising therapeutic targets in the development of novel anti-tuberculosis nitroaromatic drugs.
    Paoli-Lombardo R; Primas N; Vanelle P
    Eur J Med Chem; 2024 Aug; 274():116559. PubMed ID: 38850856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.
    Fujiwara M; Kawasaki M; Hariguchi N; Liu Y; Matsumoto M
    Tuberculosis (Edinb); 2018 Jan; 108():186-194. PubMed ID: 29523322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).
    Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE
    J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
    Lu W; Baig IA; Sun HJ; Cui CJ; Guo R; Jung IP; Wang D; Dong M; Yoon MY; Wang JG
    Eur J Med Chem; 2015 Apr; 94():298-305. PubMed ID: 25771108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
    Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
    J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles.
    Gurumurthy M; Mukherjee T; Dowd CS; Singh R; Niyomrattanakit P; Tay JA; Nayyar A; Lee YS; Cherian J; Boshoff HI; Dick T; Barry CE; Manjunatha UH
    FEBS J; 2012 Jan; 279(1):113-25. PubMed ID: 22023140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor.
    Somasundaram S; Anand RS; Venkatesan P; Paramasivan CN
    BMC Microbiol; 2013 Oct; 13():218. PubMed ID: 24083570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of antimycobacterial activity of riboflavin derivatives.
    Harale B; Kidwai S; Ojha D; Singh M; Chouhan DK; Singh R; Khedkar V; Rode AB
    Bioorg Med Chem Lett; 2021 Sep; 48():128236. PubMed ID: 34242760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.
    Macchi FS; Pissinate K; Villela AD; Abbadi BL; Rodrigues-Junior V; Nabinger DD; Altenhofen S; Sperotto N; da Silva Dadda A; Subtil FT; de Freitas TF; Erhart Rauber AP; Borsoi AF; Bonan CD; Bizarro CV; Basso LA; Santos DS; Machado P
    Eur J Med Chem; 2018 Jul; 155():153-164. PubMed ID: 29885576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protonation state of F420H2 in the prodrug-activating deazaflavin dependent nitroreductase (Ddn) from Mycobacterium tuberculosis.
    Mohamed AE; Ahmed FH; Arulmozhiraja S; Lin CY; Taylor MC; Krausz ER; Jackson CJ; Coote ML
    Mol Biosyst; 2016 Apr; 12(4):1110-3. PubMed ID: 26876228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
    Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
    Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting
    Berida T; McKee SR; Chatterjee S; Manning DL; Li W; Pandey P; Tripathi SK; Mreyoud Y; Smirnov A; Doerksen RJ; Jackson M; Ducho C; Stallings CL; Roy S
    ACS Infect Dis; 2023 Nov; 9(11):2282-2298. PubMed ID: 37788674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycobacterial activity of diphenylpyraline derivatives.
    Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W
    Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology. An antibiotic mimics immunity.
    Nathan C
    Science; 2008 Nov; 322(5906):1337-8. PubMed ID: 19039126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.